Full Text View
Tabular View
No Study Results Posted
Related Studies
Visudyne® in Occult (VIO)
This study has been completed.
Study NCT00121407   Information provided by QLT Inc
First Received: July 12, 2005   Last Updated: July 19, 2005   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Macular Degeneration
Additional conditions recognized in this trial
Choroidal Neovascularization
More general conditions related to this trial
Choroid Diseases
Eye Diseases
Metaplasia
Neovascularization, Pathologic
Pathologic Processes
Retinal Degeneration
Retinal Diseases
Uveal Diseases
Interventions listed in this trial
Visudyne for injection
Additional drug interventions recognized in this trial
Verteporfin
More general drug interventions related to this trial
Dermatologic Agents
Pharmacologic Actions
Photosensitizing Agents
Physiological Effects of Drugs
Radiation-Sensitizing Agents
Therapeutic Uses
Sponsors listed in this trial
QLT Inc


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services